Leukocyte adhesion deficiency (LAD)

Leukocyte adhesion deficiency (LAD) is a primary immunodeficiency in which leukocytes, especially neutrophils, cannot adhere to endothelium and migrate into infected tissue. In Immunobiology, it shows how integrins and cell trafficking shape immune defense.

What is Leukocyte adhesion deficiency (LAD)?

Leukocyte adhesion deficiency (LAD) is a primary immunodeficiency in which white blood cells cannot stick to the blood vessel wall well enough to exit the bloodstream and reach an infection. In Immunobiology, it is a classic example of what happens when cell adhesion is broken, even though the immune cells are present and can be made in normal numbers.

The main issue is usually a defect in leukocyte integrins, especially beta-2 integrins that depend on the CD18 subunit. Integrins are adhesion proteins on the surface of leukocytes that let them bind to endothelial cells during inflammation. Without that binding step, neutrophils and other leukocytes keep circulating instead of squeezing out into tissues where bacteria are growing.

That matters because the immune response is a sequence. First, vessels near the infected area signal for help, then leukocytes roll, stick, and migrate through the endothelium, and only then do they reach the site of damage. LAD blocks the sticking and transmigration steps, so the body can detect infection but fails to send enough phagocytes where they are needed.

This is why people with LAD often get recurrent bacterial infections, delayed wound healing, and severe gum disease. A classic clue is inflammation without much pus, since pus is mostly made of neutrophils that never made it into the tissue in normal numbers. You can think of it as an emergency response with the sirens on, but the first responders cannot get out of the station.

LAD also fits into the broader topic of primary immunodeficiencies because the problem is not a missing pathogen-fighting signal, but a failure in immune cell movement. Different forms exist, but the common theme is impaired leukocyte adhesion or related trafficking steps. That makes LAD a useful case for connecting molecular defects to very visible clinical signs.

Why Leukocyte adhesion deficiency (LAD) matters in IMMUNOBIOLOGY

LAD shows how one molecular step can change the whole immune response. In Immunobiology, it is a clean example of structure changing function, because a defect in integrins on leukocytes turns into a tissue-level problem: bacteria are not cleared, wounds stay open, and inflammation looks abnormal.

It also helps you connect innate immunity to cell movement. Neutrophils are working cells, but they still have to travel to the right place before they can phagocytose pathogens. If you understand LAD, you can explain why a patient might have high infection risk even when the bone marrow is making immune cells.

This term is also useful for reading clinical clues. Recurrent bacterial infections, poor pus formation, and delayed cord separation or wound healing point you toward an adhesion problem rather than an antibody or complement problem. That kind of pattern recognition is common in immunobiology case questions and lab discussions.

LAD is a good checkpoint for the topic of primary immunodeficiencies because it forces you to think mechanistically, not just by disease name.

How Leukocyte adhesion deficiency (LAD) connects across the course

Integrins

LAD is usually caused by mutations that disrupt leukocyte integrins, especially beta-2 integrins involving CD18. If integrins cannot bind their ligands on endothelium, leukocytes cannot stop and exit the bloodstream. This makes integrins the direct molecular link between the gene defect and the infection pattern you see in patients.

Neutrophils

Neutrophils are often the main cells affected in LAD because they are the first responders that need rapid migration into infected tissue. In LAD, neutrophils may be produced, but they cannot reach the site of infection efficiently. That is why pus formation can be weak or absent even when infection is severe.

Immunodeficiency

LAD is a primary immunodeficiency, which means the immune problem comes from an inherited defect rather than from another disease or treatment. It belongs with other disorders where a specific immune step fails, such as defects in phagocytes, antibodies, or complement. The pattern of recurrent infection helps narrow the type of immune defect.

complete blood count (cbc)

A CBC can give clues in a suspected LAD case, especially if there is leukocytosis or neutrophilia during infection but little evidence that cells are reaching tissues. The test does not diagnose LAD by itself, but it can support the idea that immune cells are being made and circulating. That pushes you to think about trafficking, not production.

Is Leukocyte adhesion deficiency (LAD) on the IMMUNOBIOLOGY exam?

A quiz item or case study may describe a child with recurrent skin infections, delayed umbilical cord separation, and little pus, then ask you to identify LAD as an adhesion defect. You may also need to explain why neutrophils are present in the blood but not in infected tissue. On a lab or problem set, the key move is tracing the pathway from CD18 or integrin dysfunction to failed endothelial binding and impaired extravasation. If the question compares immune disorders, pick LAD when the clue is cell migration, not antibody levels or complement activity.

Leukocyte adhesion deficiency (LAD) vs chronic granulomatous disease (CGD)

LAD and CGD both cause recurrent bacterial infections, but the blocked step is different. In LAD, neutrophils cannot get to the infection site because adhesion and migration fail. In CGD, neutrophils can reach the tissue, but they cannot kill ingested microbes normally because the oxidative burst is defective.

Key things to remember about Leukocyte adhesion deficiency (LAD)

• Leukocyte adhesion deficiency is an inherited immunodeficiency where leukocytes cannot leave the bloodstream and enter infected tissue efficiently.

• The classic mechanism is a defect in beta-2 integrins, often involving the CD18 subunit, which prevents firm adhesion to endothelium.

• LAD usually affects neutrophil trafficking, so patients get recurrent bacterial infections, delayed wound healing, and little pus.

• The blood can show plenty of circulating leukocytes even when tissues look under-inflamed, because the cells are stuck in transit.

• If you see a case about poor leukocyte migration, think adhesion defect first, not a problem with antibody production.

Frequently asked questions about Leukocyte adhesion deficiency (LAD)

What is leukocyte adhesion deficiency (LAD) in Immunobiology?

LAD is a primary immunodeficiency caused by defective leukocyte adhesion, usually because integrins do not function properly. The immune cells are made, but they cannot bind to endothelium and migrate into infected tissue. That makes it a trafficking problem, not a pathogen-recognition problem.

Why does LAD cause recurrent bacterial infections?

Bacteria are easier to clear when neutrophils can exit blood vessels and reach the infection site quickly. In LAD, those cells stay in the circulation, so the body cannot mount an effective local response. The result is repeated bacterial infections and slow healing.

How is LAD different from chronic granulomatous disease?

Both disorders can cause recurrent infections, but LAD blocks leukocyte movement into tissues, while CGD blocks the neutrophil killing step after phagocytosis. A good clue for LAD is absent or reduced pus and poor wound healing. CGD is more about defective oxidative killing inside the phagocyte.

What lab or clinical clue points to LAD?

A classic clue is a high neutrophil count in the blood with poor neutrophil entry into tissues, along with delayed wound healing or severe gingivitis. In a case question, that pattern points you toward defective adhesion and transmigration. The problem is not cell number, but cell movement.